Skip to main content

Table 1 The diagnosis of patients included in to the retrospective database

From: Developing a research database of primary aldosteronism: rationale and baseline characteristics

  n/N (%)
Patients diagnosed as PA 862 (100%)
 Positive ARR 583/862 (67.6%)
 Screening not stated 279/862 (32.4%)
Patients with confirmation test 507/862 (55.82%)
 Positive SIT 443/507 (87.4%)
 Positive CCT 408/507 (80.5%)
 Positive both test 344/507 (67.9%)
Patients with alternative confirmation test 355/862 (41.2%)
 ARR > 20 76/355 (21.4%)
 Confirmation not stated 279/355 (78.6%)
Patients with subtype classification 479/862 (55.6%)
Adrenal vein sampling (AVS) 190/862 (22.3%)
  Unilateral disease 63/190 (33.2%)
  Bilateral disease 50/190 (26.3%)
  Unsatisfactory or indeterminate 77/190 (40.5%)
Imaging (CT/MRI etc.) 366/862 (%)
  Unilateral adenoma 345/366 (94.3%)
  Bilateral hyperplasia 21/366 (5.7%)
Patients with a definitive diagnosis 480/862 (55.7%)
Aldosterone producing adenoma (APA) 408/862 (47.3%)
  By AVS + Patho 63 /408 (15.4%)
  By imaging + Patho 345/408 (84.6%)
Bilateral aldosterone hyperplasia 72 /862 (8.4%)
  By AVS 50/72 (69.4%)
  By imaging 21/72 (29.2%)
  By patho 1/72 (1.4%)